For research use only. Not for therapeutic Use.
Batatasin III, a stilbenoid, inhibits cancer migration and invasion by suppressing epithelial to mesenchymal transition (EMT) and FAK-AKT signals. Batatasin III has anti-cancer activities[1].
Batatasin III (25-100 μM; 48 h) exhibits anti-proliferative activity in H460 cells. Batatasin III at concentrations lower than 100 μM has no cytotoxic effects[1].
Batatasin III significantly suppresses EMT indicated by the decrease of N-cadherin and Vimentin, and up-regulation of E-cadherin[1].
Catalog Number | R066445 |
CAS Number | 56684-87-8 |
Synonyms | 3-[2-(3-hydroxyphenyl)ethyl]-5-methoxyphenol |
Molecular Formula | C15H16O3 |
Purity | ≥95% |
InChI | InChI=1S/C15H16O3/c1-18-15-9-12(8-14(17)10-15)6-5-11-3-2-4-13(16)7-11/h2-4,7-10,16-17H,5-6H2,1H3 |
InChIKey | VYQXIUVIYICVCM-UHFFFAOYSA-N |
SMILES | COC1=CC(=CC(=C1)O)CCC2=CC(=CC=C2)O |
Reference | [1]. Tatchakorn Pinkhien, et al. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals. Anticancer Res. 2017 Nov;37(11):6281-6289. |